Multidrug-resistant tuberculosis; (MDR TB)

i

Multidrug-resistant tuberculosis; (MDR TB)

Public Domain

April 2010
By National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.), Division of Tuberculosis Elimination.
Series: TB Elimination

Details

Alternative Title:

MDR TB
Corporate Authors:

National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.), Division of Tuberculosis Elimination.
Description:

"Multidrug-resistant TB (MDR TB) is TB that is resistant to at least two of the best anti-TB drugs, isoniazid and rifampicin. These drugs are considered first-line drugs and are used to treat all persons with TB disease." - p. 1
Content Notes:

April 2010.
Subjects:

Tuberculosis, Multidrug-Resistant
Series:

TB Elimination
Document Type:

Text
Genre:

Patient Education Handout ; Fact Sheet
Place as Subject:

United States
Pages in Document:

electronic resource; remote; 2 p. : digital, PDF file (278 KB, 2 p.)
Collection(s):

Stephen B. Thacker CDC Library
Main Document Checksum:

urn:sha-512:b149fbc012e4d358b09c8c92095c69d410170799e153ee060cfee0c3693e9876d276a17a9926bf99425e6979bbe6d825d4b74964830fc5be5cf3f09a8b18ce3b
Download URL:

https://stacks.cdc.gov/view/cdc/5883/cdc_5883_DS1.pdf
File Type:

[PDF - 279.19 KB ]

ON THIS PAGE

Details

CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners.

As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.